The following data were obtained at baseline as well as three and six months (M3, M6) after initiation of the treatment with a GLP-1-RA + UCWM or UCWM alone: body weight, monthly headache days (MHD) recorded in a headache diary, and ophthalmological assessment including visual acuity, perimetry, fundoscopy, optical coherence tomography (OCT) and ocular ultrasonography
Quick answer Semaglutide is usually the clearest first GLP-1 choice for people who want a well-studied weekly medication, strong appetite control, and a familiar clinical evidence base
The actual monthly price for semaglutide injections is $259, more than twice whats advertised
During long-term follow-up, most patients continued to show a progressive improvement in urinary symptoms (decline in IPSS from 67% to 72% at weeks 20 and 85, respectively) and an enhancement of sexual function, and prostatic volume remained normal
Subsequent research will determine how it performs long-term and assess its safety for widespread use, but initial findings offer much optimism